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Case Report
Hybrid implantation of 
Cardiac resynchronization therapy device
Alexander Edo Tondas, Yoga Yuniadi
Recent trials have proven the clinical and functional benefits of cardiac 
resynchronization therapy (CRT) by biventricular pacing in patients (pts) 
with severe heart failure and intraventricular conduction delay, principally 
left bundle branch block (LBBB). However, placement of the transvenous 
left ventricular lead of CRT device is unsuccessful in 5–10% of patients and 
a further 20% fail to respond. For these groups, epicardial left ventricular 
lead placement is one alternative
A  75-year-old male patient diagnosed as non ischemic dilated cardiomyopa-
thy patient NYHA Class III-IV meeting the clinical initiation criteria of QRS 
duration > 120 msec, and low ejection fraction (≤35%), with worsening 
symptoms despite one year of medical therapy.A hybrid approach of LV 
lead implantation by mini thoracostomy and conventional implantation of 
the RA and RV leads were performed because the coronary sinus cannot 
be accessed transvenously due to small caliber even after angioplasty. The 
patient responded quite well to CRT and was discharged with stable he-
modynamics, and NYHA Functional Class II.
(J Kardiol Indones. 2010;31:126-141)
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Laporan Kasus
Advances in medical therapy seem to be improving 
survival in patients with heart failure. Among subjects 
in the Framingham study cohort, the 30-day, 1-year, and 
5-year age-adjusted mortality rates among men declined 
from 12%, 30%, and 70%, respectively, in the period 
1950–69 to 11%, 28%, and 59%, respectively, in the de-
cade 1990–99. The corresponding rates among women 
were 18%, 28%, and 57% for the period 1950–69 and 
10%, 24% and 45% for the decade 1990–99. Overall, 
there was an improvement in the survival rate after the 
onset of heart failure of 12% per decade.
Beberapa uji klinis baru-baru ini telah membuktikan keuntungan klinis dan fungsional dari terapi resinkronisasi jantung (cardiac 
resynchronization therapy, CRT) dengan pemacuan biventrikel pada pasien-pasien dengan gagal jantung berat dan gangguan 
konduksi intraventrikel, terutama left bundle branch block (LBBB). Bagaimanapun, pemasangan lead ventrikel kiri transvena 
dari alat CRT mengalami kegagalan pada 5-10% pasien dan sekitar 20% gagal berespon. Untuk kelompok pasien seperti ini, 
pemasangan lead ventrikel kiri secara epikardial dapat merupakan  salah satu alternatif. 
Seorang laki-laki usia 75 tahun didiagnosis sebagai kardiomiopati dilatasi non iskemik dengan kelas fungsional NYHA III-IV 
yang memenuhi kriteria inisiasi : durasi QRS>120 ms, dan fraksi ejeksi rendah (≤35%) dengan gejala yang memberat walaupun 
telah diterapi selama 1 tahun. Dilakukan pendekatan hibrid  pemasangan lead LV dengan mini torakostomi dan implantasi 
konvensional transvena dari lead RA dan RV karena sinus koronarius terlalu kecil sehingga tidak dapat diakses secara transvena 
walaupun telah dilakukan angioplasti. Pasien berespon cukup baik terhadap CRT dan dipulangkan 
(J Kardiol Indones. 2010;31:126-141)
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Even so, the limitations of medical therapy for 
heart failure have generated great interest in non-
pharmacological treatments. The most efficacious 
non-pharmacological treatment so far has been car-
diac resynchronization therapy (CRT) a device-based 
therapy that targets electromechanical ventricular 
dyssynchrony.1
Recent trials have proven the clinical and func-
tional benefits of cardiac resynchronization therapy 
(CRT) by biventricular pacing in patients (pts) with 
severe heart failure and intraventricular conduction 
delay, principally left bundle branch block (LBBB). In 
particular, improvements in exercise tolerance, qual-
ity of life, increased systolic heart function, reduced 
hospitalization and slowed progression of the disease 
were observed. In the
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MIRACLE-trial (453 patients) 3 the combined risk 
of death or worsening of heart failure was significantly 
lower in the CRT-group compared to the control-group 
(12 vs. 20%). Moreover, by pooling the data of five 
large, prospective randomized trials (COMPANION 
4, CONTAK-CD, InSync implantable-cardioverter 
defibrillator (ICD) 5, MIRACLE 3 and MUSTIC 6) 
the all-cause mortality is now seen to be significantly 
reduced (odds ratio 0.74, 95% confidence interval 
0.56–0.97) for the 2559 cumulative patients assigned 
either to CRT (1426 pts) or non-CRT (1133 pts) with 
a follow up duration of 6 month. To optimize CRT 
therapy, an additional lead needs to be placed in the 
right atrium to increase the preload of the failing heart 
by optimization of the atrioventricular delay. The most 
difficult part of this procedure is the implantation of 
the left ventricular (LV) lead: For CRT response, the 
LV lead has to be placed where optimal concordance 
is achieved between the left ventricular pacing site and 
the site of most delayed left ventricular mechanical 
activation 7.   
CRT systems rely on three leads: one in the right 
atrium, one fixated on the right-ventricular side of 
the ventricular septum, and another located in the 
coronary sinus.  However, placement of the trans-
venous left ventricular lead is unsuccessful in 5–10% 
of patients and a further 20% fail to respond. For these 
groups, epicardial left ventricular lead placement is 
one alternative.8
National Cardiac Center Harapan Kita (NCCHK) 
has performed seventeen CRT procedures from Janu-
ary 2005 until May 2010. Eleven of them were CRT 
and six others were CRT plus ICD (CRT-D). This is 
the second case of hybrid approach to CRT device lead 
implantation that ever been performed in NCCHK.
The purpose of this case report is to present a case 
of a hybrid approach in CRT device implantation, 
that is : a combination technique of epicardial left 
ventricle lead insertion through mini thoracotomy 
and conventional transvenous placement of the right 
atrial appendage and RV apex leads in a situation where 
placement of LV lead at the distal of anterolateral 
coronary sinus vein failed because it is too small even 
after percutaneous balloon angioplasty.
Case Illustration
A-75-year-old man, a regular patient of the National 
Cardiac Center Harapan Kita (NCCHK), labeled as 
advanced refractory heart failure was admitted with 
a plan for CRT implantation, after a discussion with 
cardiologist from a private hospital where he some-
times went for consultation due to shorter distance 
Figure 1. The effect of cardiac resynchronization therapy (CRT) on change in left 
ventricular ejection fraction (LVEF) and mortality (i.e. risk reduction) is shown com-
pared with pharmacologic therapies and implantable cardioverter defibrillator (ICD) 
therapy only. 2
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from his home. 
Seventeen years ago, he once had a medical 
checkup at the National Cardiac Center. At that time 
the treadmill test showed negative ischemic response, 
fair physical fitness, functional class one and 7,23 
mets of aerobic capacity. The resting blood pressure 
was 150/100 mmHg at rest, and 190/100 mmHg at 
the end of exercise test.  X-rays demonstrated CTR of 
50%, no buldging of pulmonary segment, an elongated 
aorta and normal pulmonary vascularization. However 
he was ignorant of his hypertension and did not seek 
a physician for treatment. Two years later he started to 
feel mild dyspnea triggered by book dust and humid 
air once in a while that prompted him to see a pul-
monologist who diagnosed him as having asthmatic 
bronchitis and chronic pulmonary obstructive disease. 
He was treated with budesonide inhalation for a while, 
but due to absence of symptoms thereafter, he did not 
continue the medication. 
The patient first noticed that he was easily fatiqued 
about one year ago. The 500 meter distance to his of-
fice, that he usually travelled everyday with ease, sud-
denly became harder to reach and he sometimes felt 
shortness of breath after the activity. After ten days of 
worsening symptoms, he then consulted a cardiologist 
at a private hospital. He presented with mild orthopnea 
and minimal rales at the base of lungs. ECG finding 
was normal but coronary MSCT screening exam 
showed severe stenosis of the left anterior descending 
and first diagonal. Ejection fraction from echocardiog-
raphy was 28%. There was an increase in creatinin 
Figure 4. Pulsed wave doppler showing : right ventricular and left ventricular (LV) preejection intervals are measured from 
the onset of the QRS on the electrocardiogram (ECG) to the onset of pulmonary (Pulm) (RV-PEI) and aortic (Ao) (LV-
PEI) outflow; IVMD is calculated by subtracting the RV-PEI from the LV-PEI.
Figure 2. Prior ECG of the patient on routine outpatient 
checkup, eight months before admission
Figure 3. ECG of the patient at the emergency department, 
four months before admission
Jurnal Kardiologi Indonesia  
130 Jurnal Kardiologi Indonesia • Vol. 31, No. 2 • Mei-Agustus 2010
level (1,6 mg%), and random blood sugar level was 
158 mg%. Furosemide was given for decongestion and 
the patient was sent to NCCHK for hospitalization 
and coronary angiography. However, catheterization 
study revealed normal left main, LAD, LCX and RCA 
coronary arteries with no significant stenosis. He was 
discharged with hypertensive heart disease , chronic 
kidney disease stage III, dyslipidemia and hyperuri-
cemia as working diagnoses and given the following 
medications : ramipril 1 x 5 mg, atorvastatin 1 x 10 
mg, aspirin 1 x 100 mg and allopurinol 1 x 300 mg.
Despite medical therapy and regular visits, the 
symptoms gradually worsened. Eight months ago he 
began to feel loss of appetite, decrease of body weight 
and weakness. He was advised to avoid strenuous ac-
tivities : taking baths with shower, having his laptop 
carried by a helper and urinating using urinals. In the 
end, he was even unable to travel to his office by foot, 
restricted by the dyspnea on effort. The symptom relief 
provided by sublingual nitrate did not seem to work 
as good and sometimes he experienced paroxysmal 
nocturnal dyspnea. He came to the outpatient clinic 
once every one or a couple of months and ECG routine 
showed sinus rhythm, QRS rate 82x/min, normal QRS 
axis, normal P wave, PR interval 0,12 sec, QRS dura-
tion 0,08 sec, no ST-T wave changes, with infrequent 
ventricular extrasystoles.
Four months ago he was admitted to NCCHK 
emergency department with complaint of atypical 
chest discomfort that has been going on for a week, 
unassociated with physical activities, with less than 2 
minutes duration. On physical exam no rales was heard 
on the lung field. Electrocardiography demonstrated 
a presumably new LBBB. That time, acute coronary 
syndrome was thought as less likely on the account of 
unspesific symptoms, and normal cardiac biomarkers 
(CKMB 10 and Troponin T <0,01). Serial cardiac 
enzymes CKMB and Troponin T were 12 and <0,01 
respectively. The patient was hospitalized and given 
intravenous diuretics. Then he was discharged with 
sinus rhythm, persisting LBBB on ECG, with QRS 
rate 83 bpm, PR interval 0,152 sec and QRS duration 
of 0.125 sec, continuing his previous medications.   
During the next few months until this last ad-
mission, the patient was hospitalized at NCCHK 
several times due to symptoms of acute heart failure. 
Throughout his disease history there was no acknowl-
edgement of typical angina or recent flu-like symp-
toms accompanied by myalgia.One time he went to a 
cardiologist at a nearby private hospital and the idea 
came that the patient might be a nonischemic dilated 
cardiomyopathy case and a candidate for CRT, which 
could be facilitated by NCCHK. 
Later at NCCHK’s, the patient underwent 
echocardiograpy assessment. There was dilatation of 
left ventricle (EDD 60 mm and ESD 55 mm) and 
left atrium (LA diameter 46 mm). Diastolic IVS dan 
LVPW thickness were 7 mm and 7 mm, respectively. 
He had low LV ejection fraction of 18% with akinetic 
septal, anteroseptal, apical and anterior segment, while 
other segments were hypokinetic. Diastolic dysfunc-
tion (compliance disturbance) was present, with E/
A>1 and deceleration time 134 msec. Right ventricular 
function was normal with TAPSE of 2 cm. Aortic cusps 
was a bit calcified, with normal function and AoVmax 
0,6 m/s. Mild mitral regurgitation, mild pulmonary 
regurgitation and mild tricuspid regurgitation (TVG 
30 mmHg) were shown on color doppler. 
Interventricular mechanical delay was 21 msec. By 
offline analysis of tissue doppler imaging, septal lateral 
delay was 30 msec, 12 segments SD was 37 msec and 
maximum difference was 90 msec. In conclusion, there 
was no interventricular dyssynchrony but borderline 
intra ventricular dyssynchrony was present. 
At the moment of admission he complained of 
productive cough and fever for the last three days. 
Blood pressure was 90/60 mmHg, heart rate 102x/
minute and respiratory rate 24x/min. Neither mur-
mur nor gallop was heard on cardiac exam. Rough 
ronchi was heard over the lower half of the lung fields. 
Laboratory exam values were: hemoglobin 13 g/dL, 
leucocyte 23.800, hematocryte 39%, thrombocyte 
265.000, ureum 126, creatinine 2,4 mg/dL, BUN 58, 
natrium 131 mmol/L,potassium 3,8 mmol/L. Chest 
Figure 5. Offline analysis of tissue doppler imaging on seg-
ments assessed for dyssynchrony
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x-ray showed enlarged heart with 60% CTR, dilated 
aorta, normal pulmonary segment, and infiltrates 
over the mid and lower right lobe of the lung. Signs 
of congestion were not prominent. 
Ultrasonography findings showed that internal 
organs, i.e. liver, gall bladder, spleen, pancreas and 
both kidneys were within normal limits with corti-
cal calcification of the left kidney. Apparently he also 
had accompanying acute on chronic kidney disease 
and community acquired pneumonia at admission. 
There was no known coronary risk factor other than 
hypertension and dyslipidemia He was treated with an-
tibiotics and IV diuretics for a few days, showing good 
clinical response. Leucocyte count reduced to 7.440 
and creatinine level returned to 1,4 mg/dL baseline. 
After he was stabilized, the first attempt of pace-
maker implantation was done. Four centimeter inci-
sion of right deltoideo-pectoralis junction area was 
made after antiseptic procedure. Puncture of the right 
subclavian vein and insertion of peel away sheath. With 
the use of Rapido and guiding catheter, the posterolat-
eral branch of coronary sinus was canulated. Placement 
of LV lead at the distal of anterolateral CS vein failed 
because the vein is too small even after POBA was 
done and the procedure was withheld.  
A week later, the patient underwent hybrid ap-
proach for CRT device implantation. Firstly, mini 
thoracotomy was performed by cardiac surgeon at 
the left ICS VI linea axillaris anterior after antiseptic 
procedure. Fluoroscopy was used to aid locating epi-
cardial CRT device implantation site. An active lead 
was inserted into the epicardium at left ventricle which 
showed : output threshold of 2.75 V, resistance of 665 
ohm, R wave of 9.7 mV and then tunneling to left 
subclavian area. Left intra pleural drain was inserted 
and the incised wound was stitched. 
The next steps was subsequently taken over by 
cardiologist who made two puncture of left subclavian 
vein. The right ventricle lead was inserted to RV apex. 
The measurement showed R wave of 6.0 mV, resistance 
of 588 ohm and threshold of 0.5 V. The RA lead was 
placed in the right atrial appendage, the measurement 
showed P wave of 7.2 mV, resistance of 688 ohm and 
threshold of 0.3 V. After fixation of lead to surrounding 
muscle and tissue, an appropriate size pocket was tai-
lored subcutaneously. Ampicillin-sulbactam 1.5 gr was 
douched. The generator was connected to the leads and 
the ECG showed biventricular pacing rhythm 60-110 
bpm. The incised wound was then stitched. CRT was set 
with St.Jude Medical Frontier™ SN, mode DDD 60-
110 bpm, bipolar. Atrial output was 3.5 V, R ventricle 
output was 3.5 V, and L ventricle output 4.0 V. 
 There was no observed complication after 
CRT. The patient suffered a little pain for a while at the 
C
Figure 6. (A) Small sized coronary sinus hindering LV lead implanta-
tion; (B) Fluoroscopy aid for locating LV lead implantation site by 
surgery; (C) Mini thoracotomy for LV lead implantation
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thoracotomy site, which can be relieved by pain killer 
medication. Clinical and hemodynamic status were 
stable during 7 days post-procedural hospital stay and 
the patient was discharged with the following medi-
cations : ramipril 1 x 5 mg, carvedilol 2 x 3.125mg, 
furosemide 1 x 40 mg tablet, spironolactone 1 x 25 
mg, aspirin 1 x 80 mg. Pre-discharge ECG indicated 
pacing rhythm with QRS rate 83 bpm, PR interval 
0,152 sec and QRS duration of 0,12 sec. Blood pres-
sure at discharge was 100/70 mmHg.
Literature Review
Dyssynchrony and Heart Failure : Epidemiol-
ogy 
Cardiac dyssynchrony has now taken its place as an 
important independent predictor of poor outcome 
in patients with CHF. In addition to well-established 
predictors of mortality – age, degree of systolic impair-
ment, ejection fraction, New York Heart Association 
(NYHA) function class – data now show QRS pro-
longation and/or evidence of mechanical contractile 
dysynchrony to be independent predictors as well. The 
mortality risk increased by 45% in the CHF-STAT 
cohort of 669 dilated cardiomyopathy patients if their 
QRS duration exceeded 120 ms.12 The larger Italian 
Network on CHF Registry (5500 subjects) found 
that the presence of a LBBB (which occurred in 25% 
of the cohort) was an independent predictor of both 
annual overall mortality and mortality from sudden 
cardiac death. Furthermore, having an LBBB chroni-
cally increases risk. In a case–control study of more 
than 17 000 subjects (from 1958 to 2002), Imanishi 
et al 9 found LBBB occurring in less than 1%, typically 
older subjects, but that it raised their risk of dying 
from heart failure. Patients receiving pacemakers and 
developing de novo LV mechanical dyssynchrony are 
at risk as well. In a study of 11.656 patients without 
known heart failure, Freudenberger et al10 showed 
20% of paced patients suffered a new hospitalization 
for heart failure, compared with 12.5% of controls, 
and deaths from heart failure were 53% higher in the 
paced group. In addition to surface electrocardiogra-
phy, mechanical dysynchrony has also been assessed 
using newer tissue Doppler imaging methods. This has 
been shown to be a predictor of worsened outcome in 
heart failure patients, independent of QRS duration 
and other conventional factors.
Electromechanical Delay (Mechanical Dys-
synchrony)
In the failing heart, myocardial contractility is se-
verely reduced and highly dependent on preload and 
afterload. Further impairment of left ventricular (LV) 
performance and energy consumption is seen with the 
development of an electrical conduction delay, most 
frequently presenting with a prolonged PQ interval 
and a prolonged QRS complex of left bundle branch 
block (LBBB)-type morphology. The left ventricle is 
activated slowly through the septum from the right side 
and the LV endocardial activation time may exceed 100 
ms. LV pre-ejection pressure is lower than in the right 
ventricle and septal motion is abnormal. This results in 
an uncoordinated contraction sequence and delays LV 
ejection at the expense of diastolic filling. The electri-
cal conduction disturbance in patients with advanced 
heart failure may involve the complete conduction 
Figure 7. Post CRT electrocardiogram and chest x-ray.
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system from the sinus node to the Purkinje fibers. 
Thus, atrioventricular (AV) and ventricular con-
duction can be similarly affected and three different 
levels of dyssynchrony can be distinguished by echocar-
diography as proposed by Cazeau et al. 12:
• Atrioventricular dyssynchrony: delayed ventricu-
lar activation in relation to the atria owing to prolon-
gation of the PR interval (applies only to patients in 
sinus rhythm).
• Interventricular dyssynchrony: delayed onset and 
end of LV systole due to delayed LV electrical activation 
in comparison to the right ventricle.
• Intraventricular dyssynchrony: delayed activation 
of some LV segments with prolonged contraction after 
aortic valve closure.
Recent data have demonstrated that mechanical 
dyssynchrony is not necessarily related to electrical 
dyssynchrony, and that the presence of substantial 
left ventricular (LV) dyssynchrony is a major predic-
tor of response to CRT. Indeed, some patients with a 
wide QRS complex do not exhibit LV dyssynchrony, 
whereas some patients with a narrow QRS complex 
may demonstrate LV dyssynchrony. These consid-
erations suggest that the surface electrocardiogram 
may not be the optimal marker to select candidates 
for CRT.13
Hemodynamic Consequences of Dyssyn-
chrony 
The dyscoordinate contraction patterns caused by 
abnormal ventricular activation, especially during RV 
apex pacing and LBBB, induce a wealth of systolic and 
diastolic hemodynamic perturbations, which are sum-
marized in the figure below. An abnormality usually 
limited to ventricular pacing is uncoupling or improper 
timing of atrial and ventricular contraction, leading to 
impaired filling and mitral regurgitation. 
The asynchronous activation of the ventricles usu-
ally leads to inter- and intraventricular asynchrony. 
During RV pacing and LBBB, interventricular asyn-
chrony leads to delayed LV activation and consequently 
to an altered trans-septal pressure gradient that then 
leads to abrupt pre-ejection posterior interventricular 
wall motion. This may result in displacement of the 
posterior papillary muscle towards the mitral annulus, 
causing early systolic regurgitation. The increased 
intraventricular asynchrony gives rise to prolonged iso-
volumic contraction and relaxation phases  without an 
increase in the total duration of systole. Consequently, 
the duration and the extent of ejection are reduced.  
Dyscoordination between the two LV papillary 
muscles can also create mitral valve regurgitation. 
This combination of factors may lead to LV dilatation 
and increased pulmonary wedge pressure. During RV 
pacing and LBBB, the increased interventricular asyn-
chrony may also lead to an increased interval between 
left atrial and LV contraction, potentially leading to 
suboptimal LV filling and a reduction in preload. The 
effects of asynchronous electrical activation on LV 
pump function are independent of changes in preload 
and afterload. The pump function-reducing effect of 
dyssynchronous activation, induced by ventricular 
pacing or resulting from conduction disorders, has 
been observed not only under resting conditions, but 
also during various loading conditions and exercise. 
Impairments in regional and global cardiac pump func-
tion have been observed in patients and animals with 
LBBB, even if LBBB was not accompanied by other 
Figure 8. Schematic relationship between the various conse-
quences of asynchronous activation of the ventricles, from 
ventricular pacing or conduction disturbances, and the 
deterioration of pump function over time.14
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special characteristics for its particular objective. 
 The effects of CRT can be divided into acute 
and chronic effects. Studies in the acute setting have 
demonstrated that CRT abruptly enhances LV systolic 
function. In both experimental and clinical studies, 
this is manifest by a modest (6 mm Hg) rise in systolic 
pressure, increase in stroke volume (10% to 30%), 
reduction in the LV end-systolic volume and, thus, 
LV end-systolic stress, and a more rapid rise of LV 
pressure (dP/dtmax, between 15% to 35%). There 
is also improved cardiac work at similar or lower 
oxygen consumption (34) so that chamber energetic 
efficiency is improved. Many of these changes can be 
observed within a single beat upon activating CRT, 
and are sustained in the short-term studies until CRT 
is abruptly terminated where they are rapidly reversed. 
The impact of CRT on diastolic function remains 
somewhat less clear. 
Chronic CRT triggers similar changes in a number 
of hemodynamic parameters, but also results in reversal 
of LV dilation. Echocardiographic studies have shown 
>10% declines
in LV end-systolic and end-diastolic volumes, asso-
ciated with an increase in LVEF. The immediate reduc-
tion in MR severity can be attributed to an improved 
coordination of ventricular contraction, including re-
synchronized papillary muscle activation, which results 
in improved systolic function and reduced mitral leaflet 
tethering forces. This effect can be observed in patients 
with ischemic and non-ischemic cardiomyopathy. 
Effective CRT immediately reduced the transmitral 
regurgitant volume at rest by about 30% to 40% on 
average. A further 10% to 20% improvement can be 
observed after some months of CRT and is probably 
related to the LV reverse remodeling.16
cardiovascular diseases. Therefore, it seems that dys-
synchrony is an important independent determinant 
of cardiac pump function.
The combination of all these changes following 
asynchronous activation may lead to a lower cardiac 
output and systolic arterial and LV pressure.In gen-
eral, stroke volume is affected more than systolic LV 
pressure, presumably because baroreflex regulation 
partly compensates for decreases in blood pressure. 
This idea is supported by increased catecholamine 
levels and increased systemic vascular resistance during 
ventricular pacing.14
Specifications and Effects of CRT
Cardiac resynchronization therapy (CRT) is a low volt-
age stimulation therapy. In terms of the stimulating 
pulses generated by the device, CRT systems use the 
same kind of output pulse as a conventional pacemaker. 
These output pulses are generally about 1–3 V at about 
0.4 ms duration. In fact, most CRT systems, like most 
conventional pacemakers, have a maximum output of 
about 7.5–10 V. 15
Cardiac resynchronization therapy (CRT) devices 
typically rely on three leads to deliver therapy. There is 
one lead in the right atrium for atrial pacing, another 
lead affixed at or near the septum within the right 
ventricle and a third lead placed in one of the coronary 
veins in such a way that it can stimulate the left ven-
tricle. Although technically not in the left ventricle, this 
third lead is often called the LV lead. If the device is a 
CRT-D system, the lead in the right ventricle is the one 
that delivers defibrillation energy. All three leads have 
certain things in common: configuration, insulation 
and fundamental structure. Each lead also has certain 
Figure 9. Left : Three-lead system.  Right : Acute and chronic effects of CRT 15,16
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Transvenous Left Ventricular Lead Place-
ment
The question of where to place LV leads is intricately 
related to the issue of how to perform the implantation 
procedure. Historically, CRT involved direct surgical 
LV lead placement with transvenous insertion of the 
right atrial and RV leads. This approach required
general anaesthesia and lateral thoracotomy in 
advanced heart failure patients and, in the early days, 
was associated with considerable morbidity. With 
advances in techniques for retrograde coronary sinus 
cannulation, delivery systems, and dedicated LV lead 
technology, a fully transvenous approach has become 
the usual technique for CRT, although implanting the 
LV lead in a major cardiac vein may still be demanding 
and difficult in some patients. 17
Left ventricular lead placement is usually per-
formed by a transvenous approach using the tributaries 
of the coronary sinus. Intubation of the coronary sinus 
with a dedicated guiding
catheter facilitates LV lead implantation by provid-
ing support for advancing the pacing leads and allowing 
exchange of the angiography catheter and different pac-
ing leads in difficult cases. Optimal projection for iden-
tifying the ostium is the left anterior oblique projection, 
but the right anterior oblique view may aid in defining 
the angulation of sidebranch take-offs. A “conventional” 
stylet-guided pacing lead or an “over-the-wire” approach 
may be used. For the latter, a guidewire is first advanced 
into the desired branch then followed by the lead that 
has a central lumen. The “over-the-wire” technique is 
preferred for small tortuous veins, whereas conventional 
leads may provide superior stability in large veins with 
a relatively straight course; fixation is usually passive 
(anchors or pre-shaped curves). 
The feasibility of transvenous lead positioning is 
determined by anatomical and technical factors includ-
ing venous anatomy, accessibility of the vein, pacing 
threshold, lead stability, and absence of phrenic nerve 
stimulation. Venous anatomy can be evaluated during 
the procedure by retrograde venography but is also 
possible with non-invasive imaging using multislice 
computed tomography. 16
The precise incidence of suitable veins for CRT 
is not known and may differ between patients with 
ischemic and non-ischemic cardiomyopathy. Still, 
Meisel et al.18 have shown that 55% of patients have 
suitable posterior veins, whereas 99% have posterior 
or left marginal veins. Implant failures are more often 
due to enlargement of the right atrium and the ac-
companying distortion of the coronary sinus ostium 
leading to inability to cannulate the ostium (up to 
4%) or insufficient support by the guiding catheter. 
Overall, implant success rates >90% can be achieved 
in experienced centers.  
The LV lead, like other leads, requires perioperative 
testing to confirm proper placement. Testing should 
be performed before the delivery system or sheath is 
removed, in case repositioning is required. A stimu-
lus delivered from the pacing system analyzer (PSA) 
through the LV lead should cause a cardiac contraction. 
Low thresholds are ideal (a pacing threshold < 1 V 
should be considered outstanding), but LV stimula-
tion typically requires more energy than RV pacing. 
In fact, it is not unusual for an implanting physician 
to accept a relatively high pacing threshold from the 
LV lead, such as 3 V and 0.5 ms. Lower thresholds are 
clearly preferable, but the limited opportunities of LV 
lead placement may cause the implanting physician to 
accept higher thresholds 15
Coronary Sinus Angioplasty 
Difficulties result often from anatomical venous bed 
pattern, such as atypical, tortuous CS ostium anatomy, 
Figure 10. Coronary sinus anatomy and its landmarks 1
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presence of venous valve, thrombi, or stenosis, postopera-
tive deformation, functional constriction, narrowing and 
tortuosity of potential target vein, and finally, absence of 
vessels in the desired location. LV-lead placement via the 
transvenous approach can be challenging in the case of 
low phrenic nerve stimulation thresholds and/or inability 
to reach adequate coronary sinus (CS) branches. 19
Although coronary vein stenoses are rare, as noted 
by Hansky et al (4 [1.83%] of 218 patients),previous 
coronary artery bypass graft procedures, scarring after 
myocardial infarction and previous implantation of a 
CS lead are all possible etiologies for this entity. In one 
center’s experience, 10% of patients who underwent 
BVP implantation had asymptomatic coronary venous 
stenosis. Symptomatic coronary vein stenosis has not 
been reported, which is likely due to the presence of 
abundant collateral circulation.  Various methods 
adapted from interventional cardiology are used to 
resolve these problems.20 
Data on the usage of coronary sinus angioplasty 
were limited, mostly in form of case reports. Stenoses 
and small-caliber veins, as reported by  Makaryus et 
al, can be successfully dilated with standard coronary 
angioplasty catheters and stented, if necessary, for the 
optimal placement of LV BVP leads.20   An observa-
tional  study by Oskar et al analyzed eight consecutive 
patients with the indications for CRT, who needed 
additional procedures within CS to overcome techni-
cal problems during left ventricular (LV) electrode 
implantation. The analyzed group consisted of three 
subgroups: patients in whom percutaneous balloon 
angioplasty within CS was needed (n = 4); patients 
with acute instability of the lead, requiring stenting of 
the vein to fix the electrode (n = 2); and patients with 
the stenting of CS due to late dislocation of the lead 
(n = 2). Success rate, procedure duration, fluoroscopy, 
complications, and electrical parameters of leads were 
analyzed. Success rate of the procedures was 87.5%; 
additional interventions increased overall efficacy of 
CRT implantation at our center from 88% to 98% 
(P < 0.05). Procedure duration (155.0 minute) and 
fluoroscopy time (42.5 minute) remained acceptable 
for the patient and operator; however, both were 
higher than in the procedures performed routinely in 
our hospital. Electrical properties of the LV leads were 
stable and within normal ranges during the observation 
period. We noted two local dissections of CS during 
the procedure, which remained clinically silent.21
Patients who undergo coronary venous stent 
implantation are  usually not initiated or maintained 
on antiplatelet therapy. As with any new technique, 
however, caution is advised with this novel procedure. 
It should only be performed in centers with extensive 
experience in the combined techniques of transvenous 
LV leads and PTCA. Potential complications include 
venous rupture, resulting in cardiac tamponade and 
interference with lead threshold. The question of the 
limits of balloon inflation needs further investigation 
in order to minimize the risk of venous rupture. Other 
complications include access site complications due 
to inadequate length of the delivery catheter, and 
infection through the open-wound access site in the 
chest wall. Another complication involves throm-
bosis of the coronary sinus. This, however, has not 
been reported to result in significant complications. 
Further study also needs to be undertaken with re-
spect to the long-term effects of stent implantation 
in the coronary venous system. A multidisciplinary 
team consisting of an interventional cardiologist and 
electrophysiologist is advised, with cardiac surgical 
backup available.20
Caveats in Coronary Sinus Lead Implanta-
tion
In an early reported, 6 year experience of biventricular 
pacing the overall procedural success rate in 116 pa-
tients was 88%,49 although there was a high rate of 
re-intervention due to LV lead dislodgement, increase 
in LV pacing threshold, phrenic nerve stimulation, and 
infection. A learning curve and technological develop-
ments enabled the reported procedural success to rise 
from 69% in the first year to 98% in the final year of 
this early study. In the MIRACLE study, transvenous 
CRT implants failed in 8% of patients; coronary sinus or 
coronary vein dissection/perforation occurred in 6% of 
implants; combined complete heart block, haemoperi-
cardium, and cardiac arrest were observed in 1.2%; and 
two patients died as a result of complications related to 
the implantation within a month after the procedure.3 
Lead technology and technical success has im-
proved, and in a more recent report on the procedural 
characteristics of over 450 CRT implants in the land-
mark CARE-HF7 study, the overall implant success 
rate was 95.9%. Early complications (<24 h) were 
seen in 10% of patients largely due to lead dislodge-
ment and coronary sinus dissection or perforation and 
late complications (between 24 h and 30 days) were 
reported in a further 5.5% of implants and attributed 
largely to lead displacement. 
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Institutional and individual experience, together 
with improved equipment, will ensure the success rate 
of CRT remains high. To date, the overall CRT implant 
experience suggests that transvenous implantation of 
LV pacing leads provides an effective, well-tolerated 
approach to biventricular pacing. Procedural success 
is over 90% with a 30-day all-cause mortality of 1.5% 
and a ≈10% risk of a second procedure for LV lead 
dislodgement, extracardiac stimulation, or infection 
after an initial successful implant. 
Even though the ability to secure LV leads in a 
major cardiac vein through coronary sinus cannula-
tion is increasingly feasible, procedural success does 
not appear to herald a major shift in the clinical and 
echocardiographic response rate of CRT. The particular 
coronary vein used for the LV lead may be important 
and is of course dependent on individual coronary 
venous anatomy. 17,18
In one series, placement of the LV lead tip in the 
intended target area (namely lateral, anterolateral, or 
posterolateral tributaries of the coronary sinus) was 
achieved in only 70% of cases. A variety of coronary 
veins are employed for the LV lead: Alonso et al report-
ed that 36% of LV leads were placed in the anterior and 
middle cardiac veins; in the Easytrak Registry (2001), 
67% of LV leads were placed in lateral or posterior 
coronary veins; and Molhoek et al. reported that 35% 
were placed in posterior veins and 28% in lateral veins. 
When coronary lead position is reviewed in the context 
of area of latest LV myocardial activation, LV lead tip 
concordance to, or in the vicinity of, the region with 
maximal delay was seen in only 64.8% (35 of 54) and 
55.2% (32 of 58) patients, respectively. 
Therefore, although a feasible implant technique, 
the coronary venous anatomy may limit placement of 
the LV lead and the ability to pace a defined region 
of the LV for CRT via the transvenous route. Direct 
surgical epicardial LV lead placement may overcome 
these limitations and provide the potential to pace the 
optimal target site. 17,18
Discussion
Candidate for Cardiac Resynchronization 
Therapy
Cardiac resynchronization therapy (CRT) is a well-
accepted, device-based intervention for patients with 
dilated cardiomyopathy and heart failure symptoms.
The efficacy of CRT in improving morbidity and 
mortality in such patients has been explored through 
scores of large and small trials. Accordingly, the most 
recent recommendations from some of the major car-
diac societies have been to strongly endorse CRT in a 
selected population. A high level of evidence supports 
CRT in patients with systolic dysfunction, for example, 
an LVEF ≤35%, a QRS complex duration >120 ms, 
in sinus rhythm, and who remain symptomatic (as in 
New York Heart Association (NYHA) functional class 
III or IV)despite optimal or maximal medical therapy.
Unfortunately, there are no additional clues in any 
of the guidelines as to what constitutes optimal medical 
therapy before CRT should be considered. Clinicians 
must make reasonable judgments not only about the 
kind of medications on which their individual patients 
should be maintained, but also for how long the pa-
tients should be observed on medical therapy alone. 
Furthermore, it is not clear what criteria should be 
used to determine failed medical therapy.
Anyway, this patient had met the criteria for 
CRT initiation, namely : low LV ejection fraction 
(18%), NYHA functional class III-IV, QRS duration 
of 125 msec (>120 msec) , sinus rhythm. He had 
been treated with ACE inhibitors and loop diuretics 
for approximately one year without significant im-
provement.  The addition of an evidence-based beta 
blocker to an ACE inhibitor might results in a 35% 
reduction in annual mortality related to heart failure. 
Beta blockers have now been evaluated in over 20.000 
heart failure patients and have been shown to possess 
a remarkable capacity for improving LV function and 
survival in patients with mild to severe symptoms, 
of both genders, and all age ranges. Following 4–6 
months of treatment with an evidence-based beta 
blocker, one will expect an improvement in LVEF by 
at least 5–10% associated with an improvement in 
symptoms and functional capacity. Not infrequently, 
one may see a dramatic improvement in LV function 
and symptoms, particularly in those patients with 
hypertensive or dilated cardiomyopathy. The primary 
action of beta blockers is to counteract the harmful 
effects of the sympathetic nervous system activated 
during heart failure.22
Currently, there are three beta blockers that have 
been approved for heart failure management based 
upon results from large clinical trials. These drugs are 
the selective beta-1 antagonists metoprolol succinate 
and bisoprolol, and an agent with beta-1, beta-2, and 
alpha-1 blocking properties, carvedilol. ISDN/H, 
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digoxin, and ARBs may be added to ACE inhibitor, 
beta blocker, and diuretic therapy for those with per-
sistent heart failure symptoms. Use of an aldosterone 
antagonist with an ACE inhibitor and ARB should be 
used with caution because of the risk of life-threatening 
hyperkalemia, especially in cases of renal insufficiency 
just like this patient.
Echo Assessment of Dyssynchrony
The measurement of QRS duration by the ECG – an 
electrical phenomenon which provides only a crude 
estimation on myocardial activation – is poorly cor-
related with the presence of mechanical dyssynchrony. 
In contrast, transthoracic echocardiography allows the 
severity of mechanical dyssynchrony and its impact 
on cardiac hemodynamics to be assessed immediately 
online and in a quantitative manner.
Echocardiography therefore seems a more reliable 
tool for correctly identifying suitable CRT candidates, 
thus reducing the number of clinical nonresponders. 
Despite the obvious advantages of this widely available 
bedside imaging technique, at present QRS duration 
still remains the main selection criterion for diagnosing 
the presence of mechanical dyssynchrony in clinical 
practice and in the currently available guidelines. This 
is mainly because the large prospective, randomized 
trials solely relied on the QRS width as the only marker 
for dyssynchrony. 11
Interventricular dyssynchrony can be evaluated 
by assessing the extent of interventricular mechanical 
delay (IVMD), defined as the time difference between 
left and right ventricular pre-ejection intervals. An 
IVMD ≥40 ms is considered indicative of interven-
tricular dyssynchrony.
M-mode echocardiography may be useful for as-
sessing intraventricular dyssynchrony . Using an M-
mode recording from the parasternal short-axis view 
(at the papillary muscle level), the septal-to-posterior 
wall motion delay (SPWMD) can be obtained and a 
cut-off value ≥130 ms was proposed as a marker of 
intraventricular dyssynchrony. However, frequently 
the SPWMD cannot be obtained, either because the 
septum is akinetic after extensive anterior infarction or 
because the maximal posterior motion is ill-defined. In 
addition, it is often not possible to obtain perpendicu-
lar M-mode sections of the proximal LV.13
Therefore, newer echocardiographic techniques 
had been used to overcome these limitations. The ma-
jority of studies have used color-coded tissue doppler 
to assess LV dyssynchrony and predict outcome, and 
it is the consensus by the ASE (American Society of 
Echocardiography) writing group that this is currently 
the preferred approach.
The simplest TD approach to identify intraven-
tricular dyssynchrony by color-coded TD uses the basal 
segments of the apical 4-chamber view to measure the 
septal-to-lateral delay, known as the two-site method. 
Subsequently, a 4-segment model was applied that 
included 4 basal segments (septal, lateral, inferior, 
and anterior). An opposing wall delay greater than or 
equal to 65 milliseconds allowed prediction of both 
clinical response to CRT (defined by an improvement 
in NYHA class and 6-minute walking distance) and 
reverse remodeling (defined as a ≥15% reduction in 
LV end-systolic volume). In addition, patients with LV 
dyssynchrony greater than or equal to 65 milliseconds 
had a favorable prognosis after CRT.
Yu et al. used TDI to assess intraventricular dys-
synchrony in 88 normal individuals, 67 patients with 
Figure 11. Guidelines for resynchronization therapy in heart failure 23
Tondas E dkk: Hybrid implantation of CRT
139Jurnal Kardiologi Indonesia • Vol. 31, No. 2 • Mei-Agustus 2010
heart failure and a narrow QRS complex (≤120 ms), 
and 45 with a wide QRS complex (>120 ms).In this 
study, 12 sample volumes were placed in the myocar-
dium, and for each sample the time from onset of QRS 
complex to peak systolic velocity was measured. From 
these data, two parameters indicating intraventricular 
dyssynchrony were derived: the maximal difference 
between peak systolic velocities of any 2 of the 12 
segments (intraventricular dyssynchrony defined as a 
difference >100 ms); and the SD of all 12 time intervals 
measuring time to peak systolic velocity (intraventricu-
lar dyssynchrony defined as a standard deviation of 33 
ms, also referred to as dyssynchrony index).23
This patient do not meet echocardiographic 
criteria for interventricular dyssynchrony (IVMD 
≤ 40 ms), and only borderline intraventricular dys-
synchrony criteria, but CRT was initiated using ECG 
criteria according to guidelines. However, with cur-
rent echocardiographic techniques, including TDI 
and tissue synchronization imaging, it is possible to 
precisely locate (before device implantation) the site 
of latest activation that will allow determination of the 
feasibility of a transvenous approach. When the site of 
latest activation is not in the region of suitable veins, 
surgical LV lead positioning may be considered, using 
limited left-lateral thoracotomy with direct epicardial 
lead placement.23
Which is Better : Transvenous or Surgical LV 
lead implantation ?
Navia and colleagues reported on 41 patients under-
going minimally invasive lead placement following 
failed CS lead insertion. Twenty-three of these patients 
underwent mini-thoracotomy, and 18 underwent an 
endoscopic approach (14 thoracoscopic and 4 robotic-
posterior approach). The patient population described 
was quite ill, with 46% of the patients in hospital with 
a heart failure exacerbation. Of note, a preoperative 
LV mapping protocol of tissue Doppler imaging (TDI) 
was used to target the optimal site of LV pacing. 
Similarly, postoperative echocardiography-guided 
optimization of LV pacing was performed on postop-
erative day 2. All patients had two LV leads successfully 
placed and there were no endoscopic conversions. 
Seventy-eight per cent of patients were extubated 
in the operating room. Two patients had prolonged 
respiratory failure. Mean ICU stay was 1.5 days and 
hospital stay was 4 days. There was no difference 
between minithoracotomy patients and endoscopic 
patients in terms of length of stay or extubation time. 
Over a 6-month follow-up there were 6 deaths and 34 
clinical responders for an overall response rate of 73%. 
Interestingly, both responders and non-responders had 
documentation of resynchronization via TDI. Despite 
resynchronization, it is postulated that other factors, 
including severe ventricular systolic and diastolic 
dysfunction, can impact heavily on clinical outcome.
Koos et al. compared transvenous lead placement 
vs. lateral thoracotomy in 81 patients undergoing CRT. 
Patients who underwent surgical lead implantation 
had a much lower rate of re-intervention but increased 
length of hospital admission, reduced improvement 
in functional capacity, and a tendency to less reverse 
remodeling and higher mortality at 1-year follow-up.. 
The crucial feature of this study is that many of the LV 
leads in the surgical group were positioned anteriorly 
(44%) as compared to the transvenous group (4.5%). 
This study signifies the importance of posteriorly-
positioned epicardial leads as a key component in 
improved clinical and physiologic outcomes. 24
Furthermore, using mapping techniques involving 
intra-operative electrophysiological and haemody-
namic measures to optimize lead position, the leads 
were placed laterally in the area of the obtuse mar-
ginal branch of the circumflex artery in all 16 surgical 
patients studied, suggesting that a wider area of the 
LV could be targeted. The authors concluded that 
epicardial LV lead placement is a safe reliable method 
for CRT and has advantages regarding lead-related 
complications and the necessity for reoperation. 
Although no prospective, randomized comparison 
has yet been performed between surgical epicardial LV 
lead placement and CS lead placement, Mair et al. have 
reported results on a retrospective comparison. The 
study group included 79 patients undergoing CS lead 
insertion and 16 patients undergoing LV epicardial lead 
placement through a limited left lateral thoracotomy. 
The patients undergoing surgically placed LV leads 
included nine patients with failed CS leads and seven 
patients undergoing primary implant. All patients 
undergoing surgical placement of the epicardial LV 
lead achieved posterolateral lead placement as opposed 
to only 70% in the transvenous CS group. Length of 
stay was not statistically different between the two 
groups. Over a mean follow-up of 16 months, CS lead 
thresholds were significantly higher than surgically 
placed epicardial leads, with seven CS leads having a 
pacing threshold of > 4 V/0.5 ms vs. no epicardial leads 
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with a pacing threshold > 1.8 V/0.5 ms. In follow-up, 
25 CS lead-related complications occurred, compared 
with one in the surgical group.24
In a newer prospective longitudinal study by 
Patwala et al, twenty-three subjects with unsuccessful 
transvenous coronary sinus lead placement underwent 
epicardial implantation. The subjects underwent clini-
cal evaluation, cardiopulmonary exercise testing, and 
echocardiography before 3 and 6 months after. The 
results were compared with a control group (n = 35) 
who had received transvenous CRT. In both groups, 
there were significant improvements in all measures at 
3 and 6 months. The improvement in peak VO2 was 
delayed in the epicardial group compared with the 
transvenous group. At 6 months, the improvements 
seen in all variables showed no difference between the 
groups. The authors concluded that epicardial lead 
placement is a viable option for patients with unsuc-
cessful coronary sinus lead placement. The improve-
ments in most variables were of a similar magnitude 
and over a similar time scale compared with trans-
venous placement. Improvements in peak VO2 were 
delayed in the epicardial group, probably as a result of 
a prolonged recovery time. 8
An alternative method of transseptal endocardial 
LV pacing has been proposed and, in a small cohort 
of 10 patients, appears to be feasible. In a single case 
report, transapical endocardial LV lead placement to 
the lateral free wall has been described and appears to 
be feasible particularly in patients where epicardial LV 
lead placement may be complicated by extensive peri-
cardial adhesions from previous cardiac surgery.Clearly 
safety and efficacy data for both of these techniques at 
present are lacking but these approaches may offer an 
alternative to surgical lead placement.24
Summary
We have presented a case of CRT in a  75-year-old 
male patient diagnosed as non ischemic dilated car-
diomyopathy patient NYHA Class III-IV meeting the 
initiation criteria of QRS duration > 120 msec, and low 
ejection fraction (≤35%), with worsening symptoms 
despite one year of medical therapy. Echocardiographic 
assessment showed no interventricular dyssynchrony 
and borderline intraventricular dyssynchrony. A hybrid 
approach of LV lead implantation by mini thoracos-
tomy and conventional implantation of the RA and 
RV leads were performed because the coronary sinus 
cannot be accessed transvenously due to small size even 
after angioplasty.   
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